Cargando…
Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
Autores principales: | Stokol, Tracy, Serpa, Priscila B. S., Zahid, Muhammad N., Brooks, Marjory B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302014/ https://www.ncbi.nlm.nih.gov/pubmed/28194402 http://dx.doi.org/10.3389/fvets.2017.00010 |
Ejemplares similares
-
Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
por: Stokol, Tracy, et al.
Publicado: (2016) -
Subcutaneous Administration of Low-Molecular-Weight Heparin to Horses Inhibits Ex Vivo Equine Herpesvirus Type 1-Induced Platelet Activation
por: Stokol, Tracy, et al.
Publicado: (2018) -
Editorial: Current Research in Equid Herpesvirus Type-1 (EHV-1)
por: Stokol, Tracy, et al.
Publicado: (2020) -
Pharmacokinetics and Pharmacodynamics of an Oral Formulation of Apixaban in Horses After Oral and Intravenous Administration
por: Serpa, Priscila B. S., et al.
Publicado: (2018) -
Equid Herpesvirus Type 1 Activates Platelets
por: Stokol, Tracy, et al.
Publicado: (2015)